STOCK TITAN

[144] Zai Lab Limited American SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Form 144 Notice filed by Zai Lab officer Frazor T. Edmondson for the proposed sale of 5,877 American Depositary Shares with an aggregate market value of $212,344.83 on NASDAQ, planned for June 26, 2025.

Key details of the transaction:

  • Shares were acquired through restricted stock vesting on June 25, 2025 as compensation
  • Sale is being executed through Fidelity Brokerage Services LLC
  • Purpose includes covering tax obligations from vested equity award distribution

Recent trading history shows Edmondson sold 6,243 shares in April 2025 for total proceeds of $218,867.09. The filing confirms no knowledge of material adverse non-public information regarding Zai Lab's operations. Total shares outstanding: 486,853,250.

Avviso Modulo 144 presentato dall'ufficiale di Zai Lab, Frazor T. Edmondson, per la vendita proposta di 5.877 Azioni Depositarie Americane con un valore di mercato complessivo di 212.344,83 $ sul NASDAQ, prevista per il 26 giugno 2025.

Dettagli principali della transazione:

  • Le azioni sono state acquisite tramite maturazione di azioni vincolate il 25 giugno 2025 come compenso
  • La vendita viene eseguita tramite Fidelity Brokerage Services LLC
  • Lo scopo include la copertura degli obblighi fiscali derivanti dalla distribuzione delle azioni maturate

La recente attività di trading mostra che Edmondson ha venduto 6.243 azioni nell'aprile 2025 per un ricavo totale di 218.867,09 $. La comunicazione conferma l'assenza di conoscenza di informazioni riservate materiali negative riguardanti le operazioni di Zai Lab. Totale azioni in circolazione: 486.853.250.

Aviso del Formulario 144 presentado por el ejecutivo de Zai Lab, Frazor T. Edmondson, para la venta propuesta de 5,877 Acciones Depositarías Americanas con un valor de mercado total de $212,344.83 en NASDAQ, programada para el 26 de junio de 2025.

Detalles clave de la transacción:

  • Las acciones fueron adquiridas mediante la consolidación de acciones restringidas el 25 de junio de 2025 como compensación
  • La venta se está realizando a través de Fidelity Brokerage Services LLC
  • El propósito incluye cubrir obligaciones fiscales derivadas de la distribución de acciones consolidadas

El historial reciente de operaciones muestra que Edmondson vendió 6,243 acciones en abril de 2025 por un total de $218,867.09. La presentación confirma que no se posee información confidencial material adversa respecto a las operaciones de Zai Lab. Total de acciones en circulación: 486,853,250.

Form 144 신고서가 Zai Lab 임원 Frazor T. Edmondson에 의해 제출되었으며, 2025년 6월 26일 NASDAQ에서 총 시장 가치 $212,344.835,877 미국 예탁 증권의 매각 예정입니다.

거래 주요 내용:

  • 주식은 2025년 6월 25일 제한 주식 권리 확정으로 보상으로 취득됨
  • 매각은 Fidelity Brokerage Services LLC를 통해 진행됨
  • 목적은 확정된 주식 보상 배분에 따른 세금 납부 의무 충당 포함

최근 거래 내역에 따르면 Edmondson은 2025년 4월에 6,243주를 매각하여 총 수익 $218,867.09를 기록했습니다. 신고서에는 Zai Lab의 운영과 관련된 중요 비공개 부정적 정보가 없음을 확인합니다. 총 발행 주식 수: 486,853,250주.

Avis du Formulaire 144 déposé par le dirigeant de Zai Lab, Frazor T. Edmondson, concernant la vente proposée de 5 877 American Depositary Shares d'une valeur marchande totale de 212 344,83 $ sur le NASDAQ, prévue pour le 26 juin 2025.

Détails clés de la transaction :

  • Les actions ont été acquises par l'acquisition de titres restreints le 25 juin 2025 en tant que rémunération
  • La vente est réalisée par l'intermédiaire de Fidelity Brokerage Services LLC
  • L'objectif inclut la couverture des obligations fiscales liées à la distribution des actions acquises

L'historique récent des transactions montre qu'Edmondson a vendu 6 243 actions en avril 2025 pour un produit total de 218 867,09 $. Le dépôt confirme qu'il n'existe aucune connaissance d'informations confidentielles défavorables importantes concernant les opérations de Zai Lab. Nombre total d'actions en circulation : 486 853 250.

Formular 144 Mitteilung eingereicht vom Zai Lab-Offizier Frazor T. Edmondson für den geplanten Verkauf von 5.877 American Depositary Shares mit einem Gesamtmarktwert von 212.344,83 $ an der NASDAQ, geplant für den 26. Juni 2025.

Wichtige Details der Transaktion:

  • Die Aktien wurden am 25. Juni 2025 durch die Freigabe eingeschränkter Aktien als Vergütung erworben
  • Der Verkauf erfolgt über Fidelity Brokerage Services LLC
  • Zweck ist unter anderem die Deckung von Steuerverpflichtungen aus der Verteilung der freigegebenen Aktien

Die jüngste Handelshistorie zeigt, dass Edmondson im April 2025 6.243 Aktien für Gesamterlöse von 218.867,09 $ verkauft hat. Die Meldung bestätigt, dass keine Kenntnis von wesentlichen nachteiligen nicht-öffentlichen Informationen bezüglich der Geschäftstätigkeit von Zai Lab besteht. Gesamtzahl der ausstehenden Aktien: 486.853.250.

Positive
  • None.
Negative
  • None.

Avviso Modulo 144 presentato dall'ufficiale di Zai Lab, Frazor T. Edmondson, per la vendita proposta di 5.877 Azioni Depositarie Americane con un valore di mercato complessivo di 212.344,83 $ sul NASDAQ, prevista per il 26 giugno 2025.

Dettagli principali della transazione:

  • Le azioni sono state acquisite tramite maturazione di azioni vincolate il 25 giugno 2025 come compenso
  • La vendita viene eseguita tramite Fidelity Brokerage Services LLC
  • Lo scopo include la copertura degli obblighi fiscali derivanti dalla distribuzione delle azioni maturate

La recente attività di trading mostra che Edmondson ha venduto 6.243 azioni nell'aprile 2025 per un ricavo totale di 218.867,09 $. La comunicazione conferma l'assenza di conoscenza di informazioni riservate materiali negative riguardanti le operazioni di Zai Lab. Totale azioni in circolazione: 486.853.250.

Aviso del Formulario 144 presentado por el ejecutivo de Zai Lab, Frazor T. Edmondson, para la venta propuesta de 5,877 Acciones Depositarías Americanas con un valor de mercado total de $212,344.83 en NASDAQ, programada para el 26 de junio de 2025.

Detalles clave de la transacción:

  • Las acciones fueron adquiridas mediante la consolidación de acciones restringidas el 25 de junio de 2025 como compensación
  • La venta se está realizando a través de Fidelity Brokerage Services LLC
  • El propósito incluye cubrir obligaciones fiscales derivadas de la distribución de acciones consolidadas

El historial reciente de operaciones muestra que Edmondson vendió 6,243 acciones en abril de 2025 por un total de $218,867.09. La presentación confirma que no se posee información confidencial material adversa respecto a las operaciones de Zai Lab. Total de acciones en circulación: 486,853,250.

Form 144 신고서가 Zai Lab 임원 Frazor T. Edmondson에 의해 제출되었으며, 2025년 6월 26일 NASDAQ에서 총 시장 가치 $212,344.835,877 미국 예탁 증권의 매각 예정입니다.

거래 주요 내용:

  • 주식은 2025년 6월 25일 제한 주식 권리 확정으로 보상으로 취득됨
  • 매각은 Fidelity Brokerage Services LLC를 통해 진행됨
  • 목적은 확정된 주식 보상 배분에 따른 세금 납부 의무 충당 포함

최근 거래 내역에 따르면 Edmondson은 2025년 4월에 6,243주를 매각하여 총 수익 $218,867.09를 기록했습니다. 신고서에는 Zai Lab의 운영과 관련된 중요 비공개 부정적 정보가 없음을 확인합니다. 총 발행 주식 수: 486,853,250주.

Avis du Formulaire 144 déposé par le dirigeant de Zai Lab, Frazor T. Edmondson, concernant la vente proposée de 5 877 American Depositary Shares d'une valeur marchande totale de 212 344,83 $ sur le NASDAQ, prévue pour le 26 juin 2025.

Détails clés de la transaction :

  • Les actions ont été acquises par l'acquisition de titres restreints le 25 juin 2025 en tant que rémunération
  • La vente est réalisée par l'intermédiaire de Fidelity Brokerage Services LLC
  • L'objectif inclut la couverture des obligations fiscales liées à la distribution des actions acquises

L'historique récent des transactions montre qu'Edmondson a vendu 6 243 actions en avril 2025 pour un produit total de 218 867,09 $. Le dépôt confirme qu'il n'existe aucune connaissance d'informations confidentielles défavorables importantes concernant les opérations de Zai Lab. Nombre total d'actions en circulation : 486 853 250.

Formular 144 Mitteilung eingereicht vom Zai Lab-Offizier Frazor T. Edmondson für den geplanten Verkauf von 5.877 American Depositary Shares mit einem Gesamtmarktwert von 212.344,83 $ an der NASDAQ, geplant für den 26. Juni 2025.

Wichtige Details der Transaktion:

  • Die Aktien wurden am 25. Juni 2025 durch die Freigabe eingeschränkter Aktien als Vergütung erworben
  • Der Verkauf erfolgt über Fidelity Brokerage Services LLC
  • Zweck ist unter anderem die Deckung von Steuerverpflichtungen aus der Verteilung der freigegebenen Aktien

Die jüngste Handelshistorie zeigt, dass Edmondson im April 2025 6.243 Aktien für Gesamterlöse von 218.867,09 $ verkauft hat. Die Meldung bestätigt, dass keine Kenntnis von wesentlichen nachteiligen nicht-öffentlichen Informationen bezüglich der Geschäftstätigkeit von Zai Lab besteht. Gesamtzahl der ausstehenden Aktien: 486.853.250.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many ZLAB shares is insider Frazor T. Edmondson selling on June 26, 2025?

According to the Form 144 filing, Frazor T. Edmondson plans to sell 5,877 American Depositary Shares of Zai Lab Limited (ZLAB) with an aggregate market value of $212,344.83 through Fidelity Brokerage Services LLC.

What was the reason for ZLAB insider Edmondson's share sale in June 2025?

The Form 144 filing indicates the sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution. The shares were acquired through Restricted Stock Vesting on June 25, 2025 as part of compensation.

How many ZLAB shares did Frazor Edmondson sell in the past 3 months before this Form 144?

In the three months prior to this Form 144, Edmondson sold two batches of ZLAB shares: 4,369 shares on April 2, 2025 for gross proceeds of $156,821.76, and 1,874 shares on April 4, 2025 for gross proceeds of $62,045.33, totaling 6,243 shares.

What is ZLAB's total shares outstanding according to the June 2025 Form 144?

According to the Form 144 filing, Zai Lab Limited (ZLAB) had 486,853,250 shares outstanding at the time of the filing on June 28, 2025.

What position does Frazor T. Edmondson hold at ZLAB?

The Form 144 filing indicates that Frazor T. Edmondson III's relationship to the issuer (Zai Lab Ltd) is that of an Officer of the company.
Zai Lab Limited

NASDAQ:ZLAB

ZLAB Rankings

ZLAB Latest News

ZLAB Latest SEC Filings

ZLAB Stock Data

3.96B
106.54M
1.42%
50.94%
3.61%
Biotechnology
Pharmaceutical Preparations
Link
China
SHANGHAI